NCT06753084

Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant

Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant: A Randomized Clinical Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: ahmed amer · Academic / Other
• Sex: All
• Age: 20 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

Aim of the Study To evaluate the using of porcine collagen matrix for keratinized tissue augmentation around delayed dental implant. Primary Outcome: Peri-implant keratinized mucosal width and thickness following the use of porcine collagen matrix using (Mucoderm®-Botiss gmbh) compared to the gold standard FGG augmentation. Secondary Outcome: 1. Crestal bone change (CBC) 2. Pocket depth (PD) 3. Bleeding on probing (BOP) 4. Plaque index (PI) PICOT P: Population: Patient with suitable ridge dimension for delayed implant placement. I: Intervention: Implant insertion followed by porcine collagen matrix soft tissue augmentation C: Control: Autogenous FGG O: Outcomes * Enhancing keratinized mucosal width and thickness * Evaluating : 1. Crestal bone change (CBC) 2. perimplant Pocket depth (PD) 3. Bleeding on probing (BOP) 4. Plaque index (PI) 5. Modified PES. T: Time A 6 months follow up .

Detailed description

this study aiming to augment KMW with FGG and MUCODERM following apically positioned flap the primary outcomes to measure is KMW and MT

Conditions

• Keratinized Mucosa

Interventions

Type	Name	Description
PROCEDURE	Alloderm	the study is done to patient who lacks of keratinized mucosa width by apically positioned flap and using of FGG as gold standard and Mucoderm as compartive group

Timeline

• Start date: 2023-11-01
• Primary completion: 2024-07-01
• Completion: 2024-07-25
• First posted: 2024-12-31
• Last updated: 2024-12-31

Locations

2 sites across 1 country: Egypt